SenderraRx, a premier specialty pharmacy dedicated to delivering personalized, high-touch care for patients with complex and chronic conditions, and Nautic Partners (“Nautic”) announce that Nautic has signed a definitive agreement to make a growth investment in SenderraRx. SenderraRx, founded in 2010 and headquartered in Dallas, Texas, has established itself as a trusted partner in the specialty pharmacy space, specializing in therapies for patients with complex and chronic conditions such as dermatology, rheumatology and oncology. The company has demonstrated impressive growth, earning a spot on the 2025 Inc. 5000 list for the second consecutive year with a three-year annual revenue growth rate of over 60%.
Read the full article: SenderraRx Announces Strategic Growth Investment from Nautic Partners //
Source: https://www.prnewswire.com/news-releases/senderrarx-announces-strategic-growth-investment-from-nautic-partners-302637447.html